CIPREC ( Site 0600)

CABA C1061AAS

0 studies enrolling now · 1 studies all time

What they study most

Hypercholesterolemia

Studies at this site

• Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension — Running, not enrolling